Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints
PR90366
SINGAPORE, July 1, 2021 /PRNewswire=KYODO JBN/ --
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in
musculoskeletal healthcare, today announced a partnership with OSSIS to serve
as the exclusive Asia Pacific distributor for its patient-specific 3D printed
titanium hip replacement joints.
OSSIS, a New Zealand based company, specializes in complex hip replacements
including second-time hip replacement, and replacement involving bone tumours
and trauma.
"This partnership will allow Zimmer Biomet to provide our extensive network of
orthopaedic surgeons with the option of patient-specific implants which are
crafted with a combination of clinical and engineering expertise," said Sang
Yi, Zimmer Biomet Asia Pacific Group President. "This will further strengthen
Zimmer Biomet's extensive portfolio of revision hip solutions and complementary
technologies, with the ultimate goal of providing innovative solutions for
complex cases and improving the quality of life of patients."
"The partnership with Zimmer Biomet will enhance OSSIS' ability to support
surgeons and patients alike and create a network across the Asia Pacific region
of cutting-edge technology and expert capability," said OSSIS Managing
Director, Kelvin Hyland. "This is an exciting step for OSSIS. Zimmer Biomet
shares our ethos of innovative technology, patient-specific solutions and
proven results."
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global
leader in musculoskeletal healthcare. We design, manufacture and market
orthopaedic reconstructive products; sports medicine, biologics, extremities
and trauma products; office-based technologies; spine, craniomaxillofacial and
thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the
pace of innovation. Our products and solutions help treat patients suffering
from disorders of, or injuries to, bones, joints or supporting soft tissues.
Together with healthcare professionals, we help millions of people live better
lives.
We have operations in more than 25 countries around the world and sell products
in more than 100 countries. For more information, visit www.zimmerbiomet.com or
follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
SOURCE Zimmer Biomet
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。